文献速递脑血管病神经重症与神经感染

恶性前循环卒中脑水肿增强检测(EDEMA)评分:一种风险预测工具

Enhanced Detection of Edema in Malignant Anterior Circulation Stroke (EDEMA) Score: A Risk Prediction Tool.
PubMed 文献 · Stroke · 2017-05-09

本研究基于发病24小时内的临床与影像变量,开发了预测恶性前循环卒中后潜在致死性脑水肿的EDEMA评分。该评分有助于快速识别高危患者以辅助分诊决策,但需外部验证。

要点

  • EDEMA评分利用基底池消失、血糖≥150、未接受tPA或取栓、中线移位程度及无既往卒中史预测恶性水肿。
  • 评分>7分对潜在致死性恶性水肿的阳性预测值达93%。
  • 模型区分度良好(C统计量0.76,Bootstrap验证0.75),但需外部验证。

核心结论

  • EDEMA评分可识别潜在致死性恶性水肿高危患者,有助于加快分诊决策,但需外部验证。

研究设计与样本

  • 纳入诊断为脑水肿和缺血性卒中、NIHSS≥8且发病24小时内完成头颅CT的患者,共222例。
  • 主要结局为潜在致死性恶性水肿,定义为死亡伴中线移位≥5 mm或去骨瓣减压术。
  • 对发病24小时内可用数据行多变量分析,采用Bootstrap法内部验证并构建风险评分。

主要发现

  • EDEMA评分包含以下独立预测因子:基底池消失(=3分);血糖≥150(=2分);未接受tPA或取栓(=1分);中线移位>0至3(=1分)、3至6(=2分)、6至9(=4分)、>9(=7分);无既往卒中史(=1分)。
  • 评分>7分与93%阳性预测值相关。

关键数值与推荐

  • EDEMA评分>7分对潜在致死性恶性水肿的阳性预测值为93%。

临床怎么用

  • 对于前循环卒中且NIHSS≥8的患者,可依据发病24小时内临床与影像变量计算EDEMA评分,辅助识别恶性水肿高危患者并优化监护或手术分诊。

局限性

  • 研究结论指出该评分需要外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Rapid recognition of those at high risk for malignant edema after stroke would facilitate triage for monitoring and potential surgery. Admission data may be insufficient for accurate triage decisions. We developed a risk prediction score using clinical and radiographic variables within 24 hours of ictus to better predict potentially lethal malignant edema. METHODS: Patients admitted with diagnosis codes of cerebral edema and ischemic stroke, NIHSS score (National Institute of Health Stroke Score) of ≥8 and head computed tomographies within 24 hours of stroke onset were included. Primary outcome of potentially lethal malignant edema was defined as death with midline shift ≥5 mm or decompressive hemicraniectomy. We performed multivariate analyses on data available within 24 hours of ictus. Bootstrapping was used to internally validate the model, and a risk score was constructed from the results. RESULTS: Thirty-three percent of 222 patients developed potentially lethal malignant edema. The final model C statistic was 0.76 (confidence interval, 0.68-0.82) in the derivation cohort and 0.75 (confidence interval, 0.72-0.77) in the bootstrapping validation sample. The EDEMA score (Enhanced Detection of Edema in Malignant Anterior Circulation Stroke) was developed using the following independent predictors: basal cistern effacement (=3); glucose ≥150 (=2); no tPA (tissue-type plasminogen activator) or thrombectomy (=1), midline shift >0 to 3 (=1), 3 to 6 (=2), and 6 to 9 (=4); >9 (=7); and no previous stroke (=1). A score over 7 was associated with 93% positive predictive value. CONCLUSIONS: The EDEMA score identifies patients at high risk for potentially lethal malignant edema. Although it requires external validation, this scale could help expedite triage decisions in this patient population.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ong CJ, Gluckstein J, Laurido-Soto O, et al. Enhanced Detection of Edema in Malignant Anterior Circulation Stroke (EDEMA) Score: A Risk Prediction Tool. Stroke. 2017. PMID: 28487333. doi:10.1161/STROKEAHA.117.016733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。